• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清瘦素与白癜风及其代谢紊乱之间可能存在神秘联系:一项对照性研究。

Possible enigmatic link between serum leptin and vitiligo with its metabolic derangements: A comparative controlled study.

机构信息

Department of Dermatology, Faculty of Medicine, Cairo University, Cairo, Egypt.

Department of Clinical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt.

出版信息

J Cosmet Dermatol. 2022 Jul;21(7):2971-2976. doi: 10.1111/jocd.14490. Epub 2021 Oct 3.

DOI:10.1111/jocd.14490
PMID:34601796
Abstract

OBJECTIVE

Serum leptin, an adipocytokine of interleukin-6 family, has been linked to vitiligo-associated metabolic derangements. Additionally, it has been proposed as an inflammatory mediator with possible influence on vitiligo pathogenesis. This study aimed at assessing serum leptin in vitiligo patients compared to controls and whether different vitiligo characteristics have an influence on serum leptin levels.

METHODS

In this hospital-based, cross-sectional case-control study, 70 vitiligo (35 segmental vitiligo (SV) and 35 Non-segmental vitiligo (NSV)) and 70 age- and sex-matched controls were assessed for different anthropometric measurements including waist circumference (WC), index of central obesity (ICO), and body mass index (BMI) as well as serum leptin levels.

RESULTS

Central obesity as per ICO showed no significant difference between patients and controls. Additionally, patients of SV and NSV collectively showed significant higher incidence of +ve serum leptin than their controls (41.4% vs. 22.9%%, P: 0.019). Mere presence of vitiligo and ICO >0.5 were highlighted as independent predictors of +ve serum leptin (P: 0.009 and <0.001, respectively).

LIMITATION

Inability to determine a cause/effect relationship based on a cross-sectional study. Larger scale studies are needed to affirm our findings.

CONCLUSION

Mere presence of vitiligo being an independent predictor for high serum leptin could be either a contributor to pathogenesis of vitiligo or a sequel to accumulating evidence of metabolic nature of vitiligo. This is likely to influence the investigative panel and treatment protocol for vitiligo patients.

摘要

目的

血清瘦素是白细胞介素-6 家族的一种脂肪细胞因子,与白癜风相关的代谢紊乱有关。此外,它被认为是一种具有潜在影响白癜风发病机制的炎症介质。本研究旨在评估白癜风患者与对照组的血清瘦素水平,并探讨不同的白癜风特征对血清瘦素水平的影响。

方法

在这项基于医院的横断面病例对照研究中,评估了 70 例白癜风患者(35 例节段性白癜风(SV)和 35 例非节段性白癜风(NSV))和 70 名年龄和性别匹配的对照组的不同人体测量指标,包括腰围(WC)、中心肥胖指数(ICO)和体重指数(BMI)以及血清瘦素水平。

结果

ICO 显示患者和对照组之间的中心肥胖无显著差异。此外,SV 和 NSV 患者的阳性血清瘦素发生率显著高于对照组(41.4%比 22.9%,P:0.019)。单纯存在白癜风和 ICO>0.5 是阳性血清瘦素的独立预测因素(P:分别为 0.009 和<0.001)。

局限性

由于这是一项横断面研究,因此无法确定因果关系。需要更大规模的研究来证实我们的发现。

结论

单纯存在白癜风是高血清瘦素的独立预测因素,这可能是白癜风发病机制的一个因素,也可能是白癜风代谢性质的累积证据的结果。这可能会影响白癜风患者的调查小组和治疗方案。

相似文献

1
Possible enigmatic link between serum leptin and vitiligo with its metabolic derangements: A comparative controlled study.血清瘦素与白癜风及其代谢紊乱之间可能存在神秘联系:一项对照性研究。
J Cosmet Dermatol. 2022 Jul;21(7):2971-2976. doi: 10.1111/jocd.14490. Epub 2021 Oct 3.
2
Inter-relationship of serum leptin levels with selected anthropometric parameters among a non-diabetic population: a cross-sectional study.血清瘦素水平与非糖尿病人群中部分人体测量参数的相互关系:一项横断面研究。
Eat Weight Disord. 2019 Jun;24(3):551-556. doi: 10.1007/s40519-017-0413-x. Epub 2017 Jul 7.
3
Most individuals with either segmental or non-segmental vitiligo display evidence of bilateral cochlear dysfunction.大多数节段性或非节段性白癜风患者均有双侧耳蜗功能障碍的证据。
Br J Dermatol. 2015 Feb;172(2):406-11. doi: 10.1111/bjd.13276. Epub 2014 Dec 25.
4
Effect of a 24-week weight management program on serum leptin level in correlation to anthropometric measures in obese female: A randomized controlled clinical trial.一项为期24周的体重管理计划对肥胖女性血清瘦素水平及人体测量指标的影响:一项随机对照临床试验。
Diabetes Metab Syndr. 2019 May-Jun;13(3):2230-2235. doi: 10.1016/j.dsx.2019.05.027. Epub 2019 May 25.
5
Serum 25(OH)D and adipokines levels in people with abdominal obesity.腹型肥胖人群的血清25(OH)D和脂肪因子水平
J Steroid Biochem Mol Biol. 2018 Jan;175:170-176. doi: 10.1016/j.jsbmb.2016.09.005. Epub 2016 Sep 11.
6
Obesity, Serum Resistin and Leptin Levels Linked to Coronary Artery Disease.肥胖、血清抵抗素和瘦素水平与冠状动脉疾病相关。
Arq Bras Cardiol. 2016 Oct;107(4):348-353. doi: 10.5935/abc.20160134. Epub 2016 Sep 12.
7
Circulating CXCL10 is increased in non-segmental vitiligo, in presence or absence of autoimmune thyroiditis.循环 CXCL10 在非节段性白癜风中增加,无论是否存在自身免疫性甲状腺炎。
Autoimmun Rev. 2017 Sep;16(9):946-950. doi: 10.1016/j.autrev.2017.07.006. Epub 2017 Jul 8.
8
Association of serum leptin and adiponectin with anthropomorphic indices of obesity, blood lipids and insulin resistance in a Sub-Saharan African population.撒哈拉以南非洲人群中血清瘦素和脂联素与肥胖、血脂及胰岛素抵抗人体测量指标的关联
Lipids Health Dis. 2016 May 17;15:96. doi: 10.1186/s12944-016-0264-x.
9
Serum leptin concentration, obesity, and insulin resistance in Western Samoans: cross sectional study.西萨摩亚人的血清瘦素浓度、肥胖与胰岛素抵抗:横断面研究
BMJ. 1996 Oct 19;313(7063):965-9. doi: 10.1136/bmj.313.7063.965.
10
Associations of Body Mass Index and Body Fat With Markers of Inflammation and Nutrition Among Patients Receiving Hemodialysis.接受血液透析患者的体重指数和体脂肪与炎症和营养标志物的相关性。
Am J Kidney Dis. 2017 Dec;70(6):817-825. doi: 10.1053/j.ajkd.2017.06.028. Epub 2017 Sep 1.

引用本文的文献

1
The association between metabolic syndrome and vitiligo: a systematic review.代谢综合征与白癜风之间的关联:一项系统综述。
Postepy Dermatol Alergol. 2025 Apr 15;42(2):134-142. doi: 10.5114/ada.2025.149438. eCollection 2025 Apr.
2
Risk factors for cardiovascular diseases in patients with vitiligo: an analysis of current evidence.白癜风患者心血管疾病的风险因素:当前证据分析。
Ann Med. 2024 Dec;56(1):2326297. doi: 10.1080/07853890.2024.2326297. Epub 2024 Sep 19.
3
Dietary habits in adult Japanese patients with vitiligo.成年日本白癜风患者的饮食习惯。
J Dermatol. 2024 Apr;51(4):491-508. doi: 10.1111/1346-8138.17163. Epub 2024 Feb 29.